2012 年 8 月至 2024 年 5 月，携带碳青霉烯酶基因的 ST131 在欧盟/欧洲经济区出现。
Emergence of ST131 carrying carbapenemase genes, European Union/European Economic Area, August 2012 to May 2024.
机构信息
European Centre for Disease Prevention and Control, Stockholm, Sweden.
Austrian National Reference Centre for Antimicrobial Resistance, Ordensklinikum Linz Elisabethinen, Linz, Austria.
出版信息
Euro Surveill. 2024 Nov;29(47). doi: 10.2807/1560-7917.ES.2024.29.47.2400727.
Analysis of 594 isolates of sequence type (ST)131 and its single locus variants carrying carbapenemase genes from 17 European Union/European Economic Area countries revealed acquisition of 18 carbapenemase variants, mainly in ST131 clades A and C. Most frequent were (n = 230) and (n = 224), detected in 14 and 12 countries, respectively. Isolates carrying have increased rapidly since 2021. The increasing detection of carbapenemase genes in the high-risk lineage ST131 is a public health concern.
对来自欧盟/欧洲经济区 17 个国家的 594 株携带碳青霉烯酶基因的 131 型序列（ST）及其单一位点变异株进行分析，发现获得了 18 种碳青霉烯酶变异株，主要在 ST131 亚群 A 和 C 中。最常见的是 (n=230) 和 (n=224)，分别在 14 个和 12 个国家中检测到。自 2021 年以来，携带 的菌株迅速增加。高产碳青霉烯酶基因的高危谱系 ST131 的检测不断增加，这是一个公共卫生关注的问题。
Zotero 插件